Home » Richard W. Ashley – Abbott Laboratories
More recent news
- EBR Systems raises $36.1M for leadless pacing tech
- The biggest cardiovascular tech news out of EuroPCR 2025
- CardiaWave has positive 12-month Valvosoft results
- Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
- Medtronic has new Cardiovascular, CST leaders after longtime exec departs
